Bioorganic and Medicinal Chemistry Letters p. 3577 - 3582 (1998)
Update date:2022-08-04
Topics:
Chambers
Antognoli
Cheng
Kuperman
Liston
Marfat
Owens
Pillar
Shirley
Watson
A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor antagonists Zafirlukast (1) and Pranlukast (2).
View MoreJiangxi Dongxu Chemical Science & Technology Co.,Ltd
Contact:+86-791-86899381
Address:Nanchang, Jiangxi, China
Shanghai PengMo Biotechnology Co.,Ltd
website:http://www.pengmobio.lookchem.com
Contact:86-13052359378
Address:No.218 Hai Qu Road.Shanghai.China
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Hubei Xinjing New Material Co.,Ltd
Contact:+86-27-83313147
Address:Room402.#Bthe 7th,Headquarter of Huifeng Corporation Qiaokou District,Wuhan China
HaiNan Periwinkle Pharmaceutical Co.,Ltd.
website:http://www.cchpharm.com/en/index.html
Contact:020-82208978
Address:Gongye road,Wuzhishan city,HaiNan province
Doi:10.1021/ja4098803
(2013)Doi:10.1021/ja00217a003
(1988)Doi:10.1016/j.tetlet.2013.10.156
(2014)Doi:10.1021/ja056505c
(2006)Doi:10.1016/j.tet.2020.131635
(2020)Doi:10.1002/ejoc.201801318
(2018)